ATE81011T1 - Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen. - Google Patents

Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.

Info

Publication number: ATE81011T1
Authority: AT; Austria
Prior art keywords: bismuth; gastrointestinal disorders; agent; compositions; treatment
Prior art date: 1987-03-09

Application number

AT88200397T

Other languages

English (en)

Inventor

Geoffrey Place

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-03-09

Filing date

1988-03-02

Publication date

1992-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21816102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE81011(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-03-02 Application filed by Procter & Gamble filed Critical Procter & Gamble

1992-10-15 Application granted granted Critical

1992-10-15 Publication of ATE81011T1 publication Critical patent/ATE81011T1/de

Links

208000018522 Gastrointestinal disease Diseases 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 2
229910052797 bismuth Inorganic materials 0.000 abstract 3
JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 abstract 3
239000003795 chemical substances by application Substances 0.000 abstract 3
BVPWJMCABCPUQY-UHFFFAOYSA-N 4-amino-5-chloro-2-methoxy-N-[1-(phenylmethyl)-4-piperidinyl]benzamide Chemical compound COC1=CC(N)=C(Cl)C=C1C(=O)NC1CCN(CC=2C=CC=CC=2)CC1 BVPWJMCABCPUQY-UHFFFAOYSA-N 0.000 abstract 2
230000000903 blocking effect Effects 0.000 abstract 2
239000002731 stomach secretion inhibitor Substances 0.000 abstract 2
241001465754 Metazoa Species 0.000 abstract 1
229960004645 bismuth subcitrate Drugs 0.000 abstract 1
ZREIPSZUJIFJNP-UHFFFAOYSA-K bismuth subsalicylate Chemical compound C1=CC=C2O[Bi](O)OC(=O)C2=C1 ZREIPSZUJIFJNP-UHFFFAOYSA-K 0.000 abstract 1
229960000782 bismuth subsalicylate Drugs 0.000 abstract 1
ZQUAVILLCXTKTF-UHFFFAOYSA-H bismuth;tripotassium;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [K+].[K+].[K+].[Bi+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O ZQUAVILLCXTKTF-UHFFFAOYSA-H 0.000 abstract 1
CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 abstract 1
229960001380 cimetidine Drugs 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/29—Antimony or bismuth compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/345—Nitrofurans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT88200397T 1987-03-09 1988-03-02 Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen. ATE81011T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US2359787A	1987-03-09	1987-03-09
EP88200397A EP0282132B1 (de)	1987-03-09	1988-03-02	Zusammensetzungen und ihre Verwendung zur Behandlung von Magen-Darmstörungen

Publications (1)

Publication Number	Publication Date
ATE81011T1 true ATE81011T1 (de)	1992-10-15

Family

ID=21816102

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88200397T ATE81011T1 (de)	1987-03-09	1988-03-02	Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.

Country Status (12)

Country	Link
US (1)	US5403830A (de)
EP (1)	EP0282132B1 (de)
JP (1)	JP2648327B2 (de)
KR (1)	KR960016582B1 (de)
AT (1)	ATE81011T1 (de)
AU (2)	AU621286B2 (de)
CA (1)	CA1312013C (de)
DE (1)	DE3874917T2 (de)
DK (1)	DK175968B1 (de)
HK (1)	HK94496A (de)
IE (1)	IE62071B1 (de)
NZ (1)	NZ223773A (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE81011T1 (de) *	1987-03-09	1992-10-15	Procter & Gamble	Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
IL85472A (en) *	1987-03-09	1991-06-30	Procter & Gamble	Pharmaceutical compositions for treating gastrointestinal disorders
CH679582A5 (de) *	1988-07-18	1992-03-13	Glaxo Group Ltd
AU641903B2 (en) *	1988-10-26	1993-10-07	Glaxo Group Limited	Carboxylic acid derivatives
FI910088L (fi) *	1990-01-09	1991-07-10	Gist Brocades Nv	Oral farmaceutisk komposition.
GB9009437D0 (en) *	1990-04-26	1990-06-20	Glaxo Group Ltd	Chemical compounds
GB9010039D0 (en) *	1990-05-03	1990-06-27	Reckitt & Colmann Prod Ltd	Medicament preparation
DE69117955T2 (de) *	1990-07-20	1996-09-19	Tillotts Pharma Ag, Ziefen	Produkte und verfahren zur behandlung des verdauungskanals
GB9019875D0 (en) *	1990-09-11	1990-10-24	Glaxo Group Ltd	Pharmaceutical compositions
CA2052698A1 (en) *	1990-10-11	1992-04-12	Roger G. Berlin	Treatment of peptic ulcer
US5128140A (en) *	1991-01-14	1992-07-07	The Procter & Gamble Company	Swallowable pharmaceutical compositions
US5192752A (en) *	1991-01-14	1993-03-09	The Procter & Gamble Company	Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) *	1991-09-20	1991-11-06	Glaxo Group Ltd	Medicaments
DK0550083T3 (da) *	1991-12-06	1999-10-11	Glaxo Group Ltd	Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra
GB9127150D0 (en) *	1991-12-20	1992-02-19	Smithkline Beecham Plc	Novel treatment
EP0642797B1 (de) *	1993-09-09	2000-05-17	Takeda Chemical Industries, Ltd.	Formulierung enthaltend einen antibakteriellen und einen Antiulcus Wirkstoff
BG61302B1 (bg) *	1993-09-30	1997-05-30	Нихфи Ад	n-(3-(3-(1-пиперидинилметил)фенокси)пропил)хидроксиацетамид 1,2,3-пропентрикарбоксилат бисмут /3+/комплекс и метод за получаването му
US6902738B2 (en) *	1994-05-02	2005-06-07	Josman Laboratories, Inc.	Topical oral dosage forms containing bismuth compounds
US6426085B1 (en)	1994-05-02	2002-07-30	Josman Laboratories Inc.	Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5834002A (en) *	1994-05-02	1998-11-10	Josman Laboratories, Inc.	Chewing gum containing colloidal bismuth subcitrate
WO1996019232A1 (en) *	1994-12-19	1996-06-27	Lauteral Limited	Combinations of ranitidine hydrochloride-form 1 and bismuth compounds
US6372784B1 (en)	1995-02-07	2002-04-16	Josman Laboratories, Inc.	Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en)	1995-02-07	2002-04-30	Josman Laboratories	Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US5837716A (en) *	1995-11-13	1998-11-17	Albany Medical College	Analgesic heterocyclic compounds
US6156771A (en) *	1997-08-28	2000-12-05	Rubin; Walter	Method for alleviation of lower gastrointestinal disorders in a human patient
WO2000028988A1 (en) *	1998-11-17	2000-05-25	Nitromed, Inc.	Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
US6852739B1 (en) *	1999-02-26	2005-02-08	Nitromed Inc.	Methods using proton pump inhibitors and nitric oxide donors
US6955099B2 (en) *	2002-07-19	2005-10-18	Goodin John W	Spill proof liquid sample cup
EP1534278A4 (de) *	2002-08-01	2006-09-06	Nitromed Inc	Nitrosierte protonenpumpen-hemmer, zusammensetzungen und anwendungsverfahren
JP2006067124A (ja)	2004-08-25	2006-03-09	Nec Corp	画像符号化データの切り替え方法および装置、システムならびにプログラム
US20160015647A1 (en) *	2013-03-07	2016-01-21	Capsugel Belgium Nv	Bismuth liquid filled hard capsules
KR101583452B1 (ko) *	2015-01-30	2016-01-11	주식회사 대웅제약	위장질환 치료용 의약 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2218883B1 (de) *	1973-02-28	1976-08-13	Science Union & Cie
CH638975A5 (fr) *	1979-07-27	1983-10-31	Prebuilt Ets	Composition medicamenteuse pour le traitement des ulceres gastro-duodenaux.
EP0222834A4 (de) *	1985-04-18	1989-10-04	Borody Thomas J	Behandlung von nichtulcerativer dyspepsia mit wismutsalzen.
DE3686836T2 (de) *	1985-06-13	1993-03-04	Marshall Barry James	Zusammensetzungen zur behandlung von magen-darmstoerungen.
DE3686362T2 (de) *	1985-06-13	1993-02-11	Marshall Barry James	Verfahren zur behandlung von magen-darmstoerungen.
US4959384A (en) *	1985-10-24	1990-09-25	Norwich Eaton Pharmaceuticals, Inc.	Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
IL85472A (en) *	1987-03-09	1991-06-30	Procter & Gamble	Pharmaceutical compositions for treating gastrointestinal disorders
ATE81011T1 (de) *	1987-03-09	1992-10-15	Procter & Gamble	Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
AU623868B2 (en) *	1987-10-12	1992-05-28	Capability Services Pty. Limited	Improved method for treatment of gastrointestinal disorders
CH679582A5 (de) *	1988-07-18	1992-03-13	Glaxo Group Ltd

1988
- 1988-03-02 AT AT88200397T patent/ATE81011T1/de active
- 1988-03-02 DE DE8888200397T patent/DE3874917T2/de not_active Revoked
- 1988-03-02 EP EP88200397A patent/EP0282132B1/de not_active Expired - Lifetime
- 1988-03-07 NZ NZ223773A patent/NZ223773A/en unknown
- 1988-03-08 AU AU12794/88A patent/AU621286B2/en not_active Expired
- 1988-03-08 CA CA000560793A patent/CA1312013C/en not_active Expired - Lifetime
- 1988-03-08 IE IE66488A patent/IE62071B1/en not_active IP Right Cessation
- 1988-03-09 JP JP63055925A patent/JP2648327B2/ja not_active Expired - Lifetime
- 1988-03-09 DK DK198801276A patent/DK175968B1/da not_active IP Right Cessation
- 1988-03-09 KR KR1019880002557A patent/KR960016582B1/ko not_active Expired - Lifetime
1992
- 1992-01-10 US US07/821,244 patent/US5403830A/en not_active Expired - Lifetime
- 1992-01-17 AU AU10303/92A patent/AU660956B2/en not_active Expired
1996
- 1996-05-30 HK HK94496A patent/HK94496A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR960016582B1 (ko)	1996-12-16
EP0282132B1 (de)	1992-09-30
DK127688D0 (da)	1988-03-09
EP0282132A2 (de)	1988-09-14
EP0282132A3 (en)	1989-11-15
NZ223773A (en)	1991-04-26
DK175968B1 (da)	2005-10-03
HK94496A (en)	1996-06-07
AU1030392A (en)	1992-03-05
DK127688A (da)	1988-09-10
IE62071B1 (en)	1994-12-14
DE3874917D1 (de)	1992-11-05
DE3874917T2 (de)	1993-03-04
IE880664L (en)	1988-09-09
KR880010768A (ko)	1988-10-24
JPS63290830A (ja)	1988-11-28
CA1312013C (en)	1992-12-29
AU660956B2 (en)	1995-07-13
AU621286B2 (en)	1992-03-12
US5403830A (en)	1995-04-04
JP2648327B2 (ja)	1997-08-27
AU1279488A (en)	1988-09-08

Legal Events

Date	Code	Title	Description
1993-03-15	UEP	Publication of translation of european patent specification

Publication	Publication Date	Title
ATE81011T1 (de)	1992-10-15	Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
DE3852773D1 (de)	1995-03-02	Zusammensetzungen und Verfahren zur Behandlung von Magen-Darmstörungen.
DE3579113D1 (de)	1990-09-13	Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
ATE184789T1 (de)	1999-10-15	Verwendung von carnosolsäure wegen seiner anticarcinogenen und antiviralen eigenschaften
DE3482754D1 (de)	1990-08-23	Medikament und medikamentoese zusammensetzung zur behandlung und/oder verhinderung von hautkrankheiten, verursacht durch eine entzuendung.
DE69009684D1 (de)	1994-07-14	Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen.
DK465488D0 (da)	1988-08-19	Farmaceutisk praeparat indeholdende en triazol-forbindelse
DE3584560D1 (de)	1991-12-05	Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
NO894222D0 (no)	1989-10-24	Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
EP0577025A3 (de)	1998-02-04	Angiotensin-II-Rezeptorantagonisten zur Behandlung und Prophylaxe von koronaren Herzerkrankungen
PT84564A (de)	1987-04-01	Verbindungen mit nootroper wirkung diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen
FI873429A7 (fi)	1988-02-19	Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon.
ES2044100T4 (es)	1996-07-16	Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
DE3750979D1 (de)	1995-02-23	5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung in der Behandlung neurodegenerativer Beschwerden.
NO893256D0 (no)	1989-08-14	Fremgangsmaate for fremstilling av furyltiazolderivater.
DE3586420D1 (de)	1992-09-03	Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.
DE3875637D1 (de)	1992-12-10	Zusammensetzungen und verfahren zur behandlung von magengeschwueren.
RU93003584A (ru)	1995-02-10	Способ лечения синдрома поликистозных яичников
DK277387D0 (da)	1987-05-29	Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
AT385177B (de)	1988-02-25	Fungizide mittel sowie ihre verwendung bei der bekaempfung und behandlung von pilzinfektionen an kulturpflanzen
IT1128517B (it)	1986-05-28	Composizione farmaceutica per il trattamento dell'iperacidita' gastrica gastriti e ulcere gastroduo denali
NO881798D0 (no)	1988-04-25	Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
UA12753A (uk)	1997-02-28	Спосіб лікуваhhя та профілактики респіраторhих захворюваhь молодhяка сільськогосподарських твариh змішаhої етіології
DE3887137D1 (de)	1994-02-24	Mittel zur prophylaxe und behandlung einer pankreatischen erkrannkung oder dergleichen.
ATE74511T1 (de)	1992-04-15	Behandlung von tieren mit il-2, zubereitungen dafuer und ihre herstellung.